Otsuka Holdings Co., Ltd. (TYO: 4578)

Market Cap	4.43T
Revenue (ttm)	2.18T
Net Income (ttm)	126.82B
Shares Out	541.46M
EPS (ttm)	233.67
PE Ratio	34.98
Forward PE	18.03
Dividend	120.00 (1.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	917,800
Open	8,023.00
Previous Close	8,173.00
Day's Range	7,972.00 - 8,128.00
52-Week Range	4,857.00 - 8,786.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 34,388
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2023, Otsuka Holdings's revenue was 2.02 trillion, an increase of 16.14% compared to the previous year's 1.74 trillion. Earnings were 121.62 billion, a decrease of -9.18%.